Your search:
52 result(s) in 0.17 s
-
DUKAS_160584685_FER
Device that could end insulin injections for diabetics
Ferrari Press Agency
Diabetes 1
?Ref 15098
19/09/2023
See Ferrari text
?Pictures must credit: Claudia Liu and Dr. Siddharth Krishnan, MIT/Boston Children’s Hospital
Injection-free control of diabetes could be a thing of the past thanks to a new implantable device being developed by scientists.
The device is aimed at Type 1 diabetes sufferers who need daily injections of insulin.
In the past , work has focused on implanting pancreatic cells that can produce insulin when needed, free patients from giving themselves frequent jabs.
However, one major obstacle to this is that once the cells , known as islet cells, are implanted, they eventually run out of oxygen and stop producing insulin.
To overcome that hurdle, MIT engineers have designed the new implantable device.
It carries hundreds of thousands of insulin-producing cells, but also has its own on-board oxygen factory, which generates oxygen from water vapour found in the body.
When implanted into diabetic mice, this device could keep the mice’s blood glucose levels stable for at least a month.
Researchers at Massachusetts Institute of Technology in the USA now hope to create a larger version of the device, about the size of a stick of chewing gum, that could eventually be tested in people with Type 1 diabetes.
OPS:The fully assembled device for producing oxygen to keep transplanted pancreatic insulion producing cells alive. A United States quarter-dollar coin is shown for scale.
Picture supplied by Ferrari
(FOTO: DUKAS/FERRARI PRESS) -
DUKAS_160584684_FER
Device that could end insulin injections for diabetics
Ferrari Press Agency
Diabetes 1
?Ref 15098
19/09/2023
See Ferrari text
?Pictures must credit: Claudia Liu and Dr. Siddharth Krishnan, MIT/Boston Children’s Hospital
Injection-free control of diabetes could be a thing of the past thanks to a new implantable device being developed by scientists.
The device is aimed at Type 1 diabetes sufferers who need daily injections of insulin.
In the past , work has focused on implanting pancreatic cells that can produce insulin when needed, free patients from giving themselves frequent jabs.
However, one major obstacle to this is that once the cells , known as islet cells, are implanted, they eventually run out of oxygen and stop producing insulin.
To overcome that hurdle, MIT engineers have designed the new implantable device.
It carries hundreds of thousands of insulin-producing cells, but also has its own on-board oxygen factory, which generates oxygen from water vapour found in the body.
When implanted into diabetic mice, this device could keep the mice’s blood glucose levels stable for at least a month.
Researchers at Massachusetts Institute of Technology in the USA now hope to create a larger version of the device, about the size of a stick of chewing gum, that could eventually be tested in people with Type 1 diabetes.
OPS:The fully assembled device for producing oxygen to keep transplanted pancreatic insulion producing cells alive. The device is submerged in water, generating oxygen (bottom) and hydrogen (top) bubbles without the need for any batteries or wires.
Picture supplied by Ferrari
(FOTO: DUKAS/FERRARI PRESS) -
DUK10144146_019
NEWS - Künstliche Bauchspeicheldrüse regelt den Blutzucker
Mandatory Credit: Photo by Hollandse Hoogte/Shutterstock (12211789a)
An artificial pancreas at the company Inreda Diabetic. The device, which consists of a glucose meter and a pump, regulates the release of the hormones insulin and glucagon. Both of these hormones regulate blood sugar levels.
Artificial Pancreas Step Closer to Reimbursement From Basic Package, Goor, Netherlands - 13 Jul 2021
(c) Dukas -
DUK10144146_018
NEWS - Künstliche Bauchspeicheldrüse regelt den Blutzucker
Mandatory Credit: Photo by Hollandse Hoogte/Shutterstock (12211789b)
An artificial pancreas at the company Inreda Diabetic. The device, which consists of a glucose meter and a pump, regulates the release of the hormones insulin and glucagon. Both of these hormones regulate blood sugar levels.
Artificial Pancreas Step Closer to Reimbursement From Basic Package, Goor, Netherlands - 13 Jul 2021
(c) Dukas -
DUK10144146_017
NEWS - Künstliche Bauchspeicheldrüse regelt den Blutzucker
Mandatory Credit: Photo by Hollandse Hoogte/Shutterstock (12211789f)
An artificial pancreas at the company Inreda Diabetic. The device, which consists of a glucose meter and a pump, regulates the release of the hormones insulin and glucagon. Both of these hormones regulate blood sugar levels.
Artificial Pancreas Step Closer to Reimbursement From Basic Package, Goor, Netherlands - 13 Jul 2021
(c) Dukas -
DUK10144146_016
NEWS - Künstliche Bauchspeicheldrüse regelt den Blutzucker
Mandatory Credit: Photo by Hollandse Hoogte/Shutterstock (12211789d)
An artificial pancreas at the company Inreda Diabetic. The device, which consists of a glucose meter and a pump, regulates the release of the hormones insulin and glucagon. Both of these hormones regulate blood sugar levels.
Artificial Pancreas Step Closer to Reimbursement From Basic Package, Goor, Netherlands - 13 Jul 2021
(c) Dukas -
DUK10144146_015
NEWS - Künstliche Bauchspeicheldrüse regelt den Blutzucker
Mandatory Credit: Photo by Hollandse Hoogte/Shutterstock (12211789g)
An artificial pancreas at the company Inreda Diabetic. The device, which consists of a glucose meter and a pump, regulates the release of the hormones insulin and glucagon. Both of these hormones regulate blood sugar levels.
Artificial Pancreas Step Closer to Reimbursement From Basic Package, Goor, Netherlands - 13 Jul 2021
(c) Dukas -
DUK10144146_014
NEWS - Künstliche Bauchspeicheldrüse regelt den Blutzucker
Mandatory Credit: Photo by Hollandse Hoogte/Shutterstock (12211789c)
An artificial pancreas at the company Inreda Diabetic. The device, which consists of a glucose meter and a pump, regulates the release of the hormones insulin and glucagon. Both of these hormones regulate blood sugar levels.
Artificial Pancreas Step Closer to Reimbursement From Basic Package, Goor, Netherlands - 13 Jul 2021
(c) Dukas -
DUK10144146_013
NEWS - Künstliche Bauchspeicheldrüse regelt den Blutzucker
Mandatory Credit: Photo by Hollandse Hoogte/Shutterstock (12211789e)
An artificial pancreas at the company Inreda Diabetic. The device, which consists of a glucose meter and a pump, regulates the release of the hormones insulin and glucagon. Both of these hormones regulate blood sugar levels.
Artificial Pancreas Step Closer to Reimbursement From Basic Package, Goor, Netherlands - 13 Jul 2021
(c) Dukas -
DUK10144146_012
NEWS - Künstliche Bauchspeicheldrüse regelt den Blutzucker
Mandatory Credit: Photo by Hollandse Hoogte/Shutterstock (12211789j)
An artificial pancreas at the company Inreda Diabetic. The device, which consists of a glucose meter and a pump, regulates the release of the hormones insulin and glucagon. Both of these hormones regulate blood sugar levels.
Artificial Pancreas Step Closer to Reimbursement From Basic Package, Goor, Netherlands - 13 Jul 2021
(c) Dukas -
DUK10144146_011
NEWS - Künstliche Bauchspeicheldrüse regelt den Blutzucker
Mandatory Credit: Photo by Hollandse Hoogte/Shutterstock (12211789k)
An artificial pancreas at the company Inreda Diabetic. The device, which consists of a glucose meter and a pump, regulates the release of the hormones insulin and glucagon. Both of these hormones regulate blood sugar levels.
Artificial Pancreas Step Closer to Reimbursement From Basic Package, Goor, Netherlands - 13 Jul 2021
(c) Dukas -
DUK10144146_010
NEWS - Künstliche Bauchspeicheldrüse regelt den Blutzucker
Mandatory Credit: Photo by Hollandse Hoogte/Shutterstock (12211789l)
An artificial pancreas at the company Inreda Diabetic. The device, which consists of a glucose meter and a pump, regulates the release of the hormones insulin and glucagon. Both of these hormones regulate blood sugar levels.
Artificial Pancreas Step Closer to Reimbursement From Basic Package, Goor, Netherlands - 13 Jul 2021
(c) Dukas -
DUK10144146_009
NEWS - Künstliche Bauchspeicheldrüse regelt den Blutzucker
Mandatory Credit: Photo by Hollandse Hoogte/Shutterstock (12211789h)
An artificial pancreas at the company Inreda Diabetic. The device, which consists of a glucose meter and a pump, regulates the release of the hormones insulin and glucagon. Both of these hormones regulate blood sugar levels.
Artificial Pancreas Step Closer to Reimbursement From Basic Package, Goor, Netherlands - 13 Jul 2021
(c) Dukas -
DUK10144146_008
NEWS - Künstliche Bauchspeicheldrüse regelt den Blutzucker
Mandatory Credit: Photo by Hollandse Hoogte/Shutterstock (12211789i)
An artificial pancreas at the company Inreda Diabetic. The device, which consists of a glucose meter and a pump, regulates the release of the hormones insulin and glucagon. Both of these hormones regulate blood sugar levels.
Artificial Pancreas Step Closer to Reimbursement From Basic Package, Goor, Netherlands - 13 Jul 2021
(c) Dukas -
DUK10144146_007
NEWS - Künstliche Bauchspeicheldrüse regelt den Blutzucker
Mandatory Credit: Photo by Hollandse Hoogte/Shutterstock (12211789p)
An artificial pancreas at the company Inreda Diabetic. The device, which consists of a glucose meter and a pump, regulates the release of the hormones insulin and glucagon. Both of these hormones regulate blood sugar levels.
Artificial Pancreas Step Closer to Reimbursement From Basic Package, Goor, Netherlands - 13 Jul 2021
(c) Dukas -
DUK10144146_006
NEWS - Künstliche Bauchspeicheldrüse regelt den Blutzucker
Mandatory Credit: Photo by Hollandse Hoogte/Shutterstock (12211789o)
An artificial pancreas at the company Inreda Diabetic. The device, which consists of a glucose meter and a pump, regulates the release of the hormones insulin and glucagon. Both of these hormones regulate blood sugar levels.
Artificial Pancreas Step Closer to Reimbursement From Basic Package, Goor, Netherlands - 13 Jul 2021
(c) Dukas -
DUK10144146_005
NEWS - Künstliche Bauchspeicheldrüse regelt den Blutzucker
Mandatory Credit: Photo by Hollandse Hoogte/Shutterstock (12211789m)
An artificial pancreas at the company Inreda Diabetic. The device, which consists of a glucose meter and a pump, regulates the release of the hormones insulin and glucagon. Both of these hormones regulate blood sugar levels.
Artificial Pancreas Step Closer to Reimbursement From Basic Package, Goor, Netherlands - 13 Jul 2021
(c) Dukas -
DUK10144146_004
NEWS - Künstliche Bauchspeicheldrüse regelt den Blutzucker
Mandatory Credit: Photo by Hollandse Hoogte/Shutterstock (12211789n)
An artificial pancreas at the company Inreda Diabetic. The device, which consists of a glucose meter and a pump, regulates the release of the hormones insulin and glucagon. Both of these hormones regulate blood sugar levels.
Artificial Pancreas Step Closer to Reimbursement From Basic Package, Goor, Netherlands - 13 Jul 2021
(c) Dukas -
DUK10144146_003
NEWS - Künstliche Bauchspeicheldrüse regelt den Blutzucker
Mandatory Credit: Photo by Hollandse Hoogte/Shutterstock (12211789r)
An artificial pancreas at the company Inreda Diabetic. The device, which consists of a glucose meter and a pump, regulates the release of the hormones insulin and glucagon. Both of these hormones regulate blood sugar levels.
Artificial Pancreas Step Closer to Reimbursement From Basic Package, Goor, Netherlands - 13 Jul 2021
(c) Dukas -
DUK10144146_002
NEWS - Künstliche Bauchspeicheldrüse regelt den Blutzucker
Mandatory Credit: Photo by Hollandse Hoogte/Shutterstock (12211789q)
An artificial pancreas at the company Inreda Diabetic. The device, which consists of a glucose meter and a pump, regulates the release of the hormones insulin and glucagon. Both of these hormones regulate blood sugar levels.
Artificial Pancreas Step Closer to Reimbursement From Basic Package, Goor, Netherlands - 13 Jul 2021
(c) Dukas -
DUK10144146_001
NEWS - Künstliche Bauchspeicheldrüse regelt den Blutzucker
Mandatory Credit: Photo by Hollandse Hoogte/Shutterstock (12211789s)
An artificial pancreas at the company Inreda Diabetic. The device, which consists of a glucose meter and a pump, regulates the release of the hormones insulin and glucagon. Both of these hormones regulate blood sugar levels.
Artificial Pancreas Step Closer to Reimbursement From Basic Package, Goor, Netherlands - 13 Jul 2021
(c) Dukas -
DUKAS_105699313_EYE
Woman found guilty of injecting non-diabetic girl, four, with insulin leaving her brain damaged.
Woman found guilty of injecting non-diabetic girl, four, with insulin leaving her brain damaged. On trial: Chantell Graham outside court. She is alleged to have left hospital at a critical time.
A woman has been found guilty of injecting a healthy four-year-old girl with insulin, leaving her brain damaged and severely disabled. Chantell Graham, from Tottenham, injected the young girl on two separate occasions in 2016, despite the girl not being diabetic. The first dose prompted a seizure while a second dose left her in a coma three days later. The court heard that Graham filmed the girl as she had a fit on a hospital bed. The 33-year-old had denied one count of administering a poison or noxious substance with intent and one count of administering a poison or noxious substance so as to endanger life and cruelty to a person under 16 years.But a jury at Isleworth Crown Court returned guilty verdicts on Tuesday, the CPS said.
© Alex Lentati / Evening Standard / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Evening Standard / eyevine. All Rights Reserved. -
DUKAS_105699307_EYE
Woman found guilty of injecting non-diabetic girl, four, with insulin leaving her brain damaged.
Woman found guilty of injecting non-diabetic girl, four, with insulin leaving her brain damaged. On trial: Chantell Graham outside court. She is alleged to have left hospital at a critical time.
A woman has been found guilty of injecting a healthy four-year-old girl with insulin, leaving her brain damaged and severely disabled. Chantell Graham, from Tottenham, injected the young girl on two separate occasions in 2016, despite the girl not being diabetic. The first dose prompted a seizure while a second dose left her in a coma three days later. The court heard that Graham filmed the girl as she had a fit on a hospital bed. The 33-year-old had denied one count of administering a poison or noxious substance with intent and one count of administering a poison or noxious substance so as to endanger life and cruelty to a person under 16 years.But a jury at Isleworth Crown Court returned guilty verdicts on Tuesday, the CPS said.
© Alex Lentati / Evening Standard / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Evening Standard / eyevine. All Rights Reserved. -
DUKAS_105699308_EYE
Woman found guilty of injecting non-diabetic girl, four, with insulin leaving her brain damaged.
Woman found guilty of injecting non-diabetic girl, four, with insulin leaving her brain damaged. On trial: Chantell Graham outside court. She is alleged to have left hospital at a critical time.
A woman has been found guilty of injecting a healthy four-year-old girl with insulin, leaving her brain damaged and severely disabled. Chantell Graham, from Tottenham, injected the young girl on two separate occasions in 2016, despite the girl not being diabetic. The first dose prompted a seizure while a second dose left her in a coma three days later. The court heard that Graham filmed the girl as she had a fit on a hospital bed. The 33-year-old had denied one count of administering a poison or noxious substance with intent and one count of administering a poison or noxious substance so as to endanger life and cruelty to a person under 16 years.But a jury at Isleworth Crown Court returned guilty verdicts on Tuesday, the CPS said.
© Alex Lentati / Evening Standard / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Evening Standard / eyevine. All Rights Reserved. -
DUKAS_105699236_EYE
Woman found guilty of injecting non-diabetic girl, four, with insulin leaving her brain damaged.
Woman found guilty of injecting non-diabetic girl, four, with insulin leaving her brain damaged. On trial: Chantell Graham outside court. She is alleged to have left hospital at a critical time.
A woman has been found guilty of injecting a healthy four-year-old girl with insulin, leaving her brain damaged and severely disabled. Chantell Graham, from Tottenham, injected the young girl on two separate occasions in 2016, despite the girl not being diabetic. The first dose prompted a seizure while a second dose left her in a coma three days later. The court heard that Graham filmed the girl as she had a fit on a hospital bed. The 33-year-old had denied one count of administering a poison or noxious substance with intent and one count of administering a poison or noxious substance so as to endanger life and cruelty to a person under 16 years.But a jury at Isleworth Crown Court returned guilty verdicts on Tuesday, the CPS said.
© Alex Lentati / Evening Standard / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Evening Standard / eyevine. All Rights Reserved. -
DUKAS_105699316_EYE
Woman found guilty of injecting non-diabetic girl, four, with insulin leaving her brain damaged.
Woman found guilty of injecting non-diabetic girl, four, with insulin leaving her brain damaged. On trial: Chantell Graham outside court. She is alleged to have left hospital at a critical time.
A woman has been found guilty of injecting a healthy four-year-old girl with insulin, leaving her brain damaged and severely disabled. Chantell Graham, from Tottenham, injected the young girl on two separate occasions in 2016, despite the girl not being diabetic. The first dose prompted a seizure while a second dose left her in a coma three days later. The court heard that Graham filmed the girl as she had a fit on a hospital bed. The 33-year-old had denied one count of administering a poison or noxious substance with intent and one count of administering a poison or noxious substance so as to endanger life and cruelty to a person under 16 years.But a jury at Isleworth Crown Court returned guilty verdicts on Tuesday, the CPS said.
© Alex Lentati / Evening Standard / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Evening Standard / eyevine. All Rights Reserved. -
DUKAS_105699237_EYE
Woman found guilty of injecting non-diabetic girl, four, with insulin leaving her brain damaged.
Woman found guilty of injecting non-diabetic girl, four, with insulin leaving her brain damaged. On trial: Chantell Graham outside court. She is alleged to have left hospital at a critical time.
A woman has been found guilty of injecting a healthy four-year-old girl with insulin, leaving her brain damaged and severely disabled. Chantell Graham, from Tottenham, injected the young girl on two separate occasions in 2016, despite the girl not being diabetic. The first dose prompted a seizure while a second dose left her in a coma three days later. The court heard that Graham filmed the girl as she had a fit on a hospital bed. The 33-year-old had denied one count of administering a poison or noxious substance with intent and one count of administering a poison or noxious substance so as to endanger life and cruelty to a person under 16 years.But a jury at Isleworth Crown Court returned guilty verdicts on Tuesday, the CPS said.
© Alex Lentati / Evening Standard / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Evening Standard / eyevine. All Rights Reserved. -
DUKAS_105699311_EYE
Woman found guilty of injecting non-diabetic girl, four, with insulin leaving her brain damaged.
Woman found guilty of injecting non-diabetic girl, four, with insulin leaving her brain damaged. On trial: Chantell Graham outside court. She is alleged to have left hospital at a critical time.
A woman has been found guilty of injecting a healthy four-year-old girl with insulin, leaving her brain damaged and severely disabled. Chantell Graham, from Tottenham, injected the young girl on two separate occasions in 2016, despite the girl not being diabetic. The first dose prompted a seizure while a second dose left her in a coma three days later. The court heard that Graham filmed the girl as she had a fit on a hospital bed. The 33-year-old had denied one count of administering a poison or noxious substance with intent and one count of administering a poison or noxious substance so as to endanger life and cruelty to a person under 16 years.But a jury at Isleworth Crown Court returned guilty verdicts on Tuesday, the CPS said.
© Alex Lentati / Evening Standard / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Evening Standard / eyevine. All Rights Reserved. -
DUKAS_105699315_EYE
Woman found guilty of injecting non-diabetic girl, four, with insulin leaving her brain damaged.
Woman found guilty of injecting non-diabetic girl, four, with insulin leaving her brain damaged. On trial: Chantell Graham outside court. She is alleged to have left hospital at a critical time.
A woman has been found guilty of injecting a healthy four-year-old girl with insulin, leaving her brain damaged and severely disabled. Chantell Graham, from Tottenham, injected the young girl on two separate occasions in 2016, despite the girl not being diabetic. The first dose prompted a seizure while a second dose left her in a coma three days later. The court heard that Graham filmed the girl as she had a fit on a hospital bed. The 33-year-old had denied one count of administering a poison or noxious substance with intent and one count of administering a poison or noxious substance so as to endanger life and cruelty to a person under 16 years.But a jury at Isleworth Crown Court returned guilty verdicts on Tuesday, the CPS said.
© Alex Lentati / Evening Standard / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Evening Standard / eyevine. All Rights Reserved. -
DUKAS_105699314_EYE
Woman found guilty of injecting non-diabetic girl, four, with insulin leaving her brain damaged.
Woman found guilty of injecting non-diabetic girl, four, with insulin leaving her brain damaged. On trial: Chantell Graham outside court. She is alleged to have left hospital at a critical time.
A woman has been found guilty of injecting a healthy four-year-old girl with insulin, leaving her brain damaged and severely disabled. Chantell Graham, from Tottenham, injected the young girl on two separate occasions in 2016, despite the girl not being diabetic. The first dose prompted a seizure while a second dose left her in a coma three days later. The court heard that Graham filmed the girl as she had a fit on a hospital bed. The 33-year-old had denied one count of administering a poison or noxious substance with intent and one count of administering a poison or noxious substance so as to endanger life and cruelty to a person under 16 years.But a jury at Isleworth Crown Court returned guilty verdicts on Tuesday, the CPS said.
© Alex Lentati / Evening Standard / eyevine
Contact eyevine for more information about using this image:
T: +44 (0) 20 8709 8709
E: info@eyevine.com
http://www.eyevine.com
(FOTO: DUKAS/EYEVINE)
© Evening Standard / eyevine. All Rights Reserved. -
DUK10075194_118
REPORTAGE - Mexiko: Leben mit dem Prader-Willi Syndrome
Jorge injects himself with insulin during a Sunday lunch at his family’s home in Puebla, Mexico on April 23, 2017. Jorge Antonio Moreno Gaytán, a 34-year-old Mexican man, lives with his parents in Puebla, Mexico. He was diagnosed with Prader-Willi syndrome at age seven. He weighs 136 kilos (300 pounds) and stands 152 centimeters (4 feet 12 inches). Jorge is in the process of getting bariatric surgery. As a teenager, he would pawn his siblings’ belongings in order to have money to buy food. He was also known to leave restaurants without paying. “Our worst enemy is hunger, it’s what will kill us”, Jorge says. He is now part of a sports team for people with disabilities. He has been in a relationship for 11 years with, Maria Guadalupe Pilar Saucedo Granda, known as “Lupita’, also diagnosed with Prader-Willi syndrome. Prader-Willi Syndrome (PWS) is a rare genetic disorder caused by an abnormality in chromosome 15. In newborns symptoms include weak muscle tone (hypotonia), poor appetite and slow development. In childhood the person experiences a sensation of constant hunger no matter how much he/she eats which often leads to obesity and Type 2 diabetes. There may also be mild to moderate intellectual impairment and behavioral problems. Physical characteristics include a narrow forehead, small hands and feet, short in stature, and light skin color. Prader-Willi syndrome has no known cure. However, with early diagnosis and treatment such as growth hormone therapy, the condition may improve. Strict food supervision is typically required. PWS affects an estimated 1 in 10,000 to 30,000 people worldwide. (Photo by Bénédicte Desrus/Sipa USA) *** Local Caption *** 21272629
(c) Dukas -
DUKAS_50550090_ACP
Merkel bei Sanofi
Bundeskanzlerin Angela Merkel bei der Einweihung einer neuen Fertigungslinie für Insuline beim Pharmaunternehmen Sanofi im Industriepark Höchst in Frankfurt am Main / 280515
***FRANKFURT AM MAIN, GERMANY - MAY 28: German Chancellor Angela Merkel wears a lab coat as she visits the new production facility for sterile glass vials at the Sanofi pharmaceuticals plant on May 28, 2015 in Frankfurt, Germany. Merkel is visiting the factory, which produces antibiotics and insulin, ahead of the upcoming G7 summit, where the global struggle against antibiotic-resistant bacteria is among topics to be discussed by G7 leaders. *** (FOTO: DUKAS/ACTIONPRESS)
DUKAS/ACTIONPRESS -
DUKAS_50550081_ACP
Merkel bei Sanofi
Bundeskanzlerin Angela Merkel bei der Einweihung einer neuen Fertigungslinie für Insuline beim Pharmaunternehmen Sanofi im Industriepark Höchst in Frankfurt am Main / 280515
***FRANKFURT AM MAIN, GERMANY - MAY 28: German Chancellor Angela Merkel wears a lab coat as she visits the new production facility for sterile glass vials at the Sanofi pharmaceuticals plant on May 28, 2015 in Frankfurt, Germany. Merkel is visiting the factory, which produces antibiotics and insulin, ahead of the upcoming G7 summit, where the global struggle against antibiotic-resistant bacteria is among topics to be discussed by G7 leaders. *** (FOTO: DUKAS/ACTIONPRESS)
DUKAS/ACTIONPRESS -
DUKAS_50550080_ACP
Merkel bei Sanofi
Bundeskanzlerin Angela Merkel bei der Einweihung einer neuen Fertigungslinie für Insuline beim Pharmaunternehmen Sanofi im Industriepark Höchst in Frankfurt am Main / 280515
***FRANKFURT AM MAIN, GERMANY - MAY 28: German Chancellor Angela Merkel wears a lab coat as she visits the new production facility for sterile glass vials at the Sanofi pharmaceuticals plant on May 28, 2015 in Frankfurt, Germany. Merkel is visiting the factory, which produces antibiotics and insulin, ahead of the upcoming G7 summit, where the global struggle against antibiotic-resistant bacteria is among topics to be discussed by G7 leaders. *** (FOTO: DUKAS/ACTIONPRESS)
DUKAS/ACTIONPRESS -
DUKAS_50550079_ACP
Merkel bei Sanofi
Bundeskanzlerin Angela Merkel bei der Einweihung einer neuen Fertigungslinie für Insuline beim Pharmaunternehmen Sanofi im Industriepark Höchst in Frankfurt am Main / 280515
***FRANKFURT AM MAIN, GERMANY - MAY 28: German Chancellor Angela Merkel (C) wears a lab coat as she visits the new production facility for sterile glass vials at the Sanofi pharmaceuticals plant on May 28, 2015 in Frankfurt, Germany. Merkel is visiting the factory, which produces antibiotics and insulin, ahead of the upcoming G7 summit, where the global struggle against antibiotic-resistant bacteria is among topics to be discussed by G7 leaders. *** (FOTO: DUKAS/ACTIONPRESS)
DUKAS/ACTIONPRESS -
DUKAS_50550066_ACP
Merkel bei Sanofi
Bundeskanzlerin Angela Merkel bei der Einweihung einer neuen Fertigungslinie für Insuline beim Pharmaunternehmen Sanofi im Industriepark Höchst in Frankfurt am Main / 280515
***FRANKFURT AM MAIN, GERMANY - MAY 28: German Chancellor Angela Merkel (R) wears a lab coat as she visits the new production facility for sterile glass vials at the Sanofi pharmaceuticals plant on May 28, 2015 in Frankfurt, Germany. Merkel is visiting the factory, which produces antibiotics and insulin, ahead of the upcoming G7 summit, where the global struggle against antibiotic-resistant bacteria is among topics to be discussed by G7 leaders. *** (FOTO: DUKAS/ACTIONPRESS)
DUKAS/ACTIONPRESS -
DUKAS_50550063_ACP
Merkel bei Sanofi
Bundeskanzlerin Angela Merkel bei der Einweihung einer neuen Fertigungslinie für Insuline beim Pharmaunternehmen Sanofi im Industriepark Höchst in Frankfurt am Main / 280515
***FRANKFURT AM MAIN, GERMANY - MAY 28: German Chancellor Angela Merkel (C) wears a lab coat as she visits the new production facility for sterile glass vials at the Sanofi pharmaceuticals plant on May 28, 2015 in Frankfurt, Germany. Merkel is visiting the factory, which produces antibiotics and insulin, ahead of the upcoming G7 summit, where the global struggle against antibiotic-resistant bacteria is among topics to be discussed by G7 leaders. *** (FOTO: DUKAS/ACTIONPRESS)
DUKAS/ACTIONPRESS -
DUKAS_50550059_ACP
Merkel bei Sanofi
Bundeskanzlerin Angela Merkel bei der Einweihung einer neuen Fertigungslinie für Insuline beim Pharmaunternehmen Sanofi im Industriepark Höchst in Frankfurt am Main / 280515
***FRANKFURT AM MAIN, GERMANY - MAY 28: German Chancellor Angela Merkel (R) wears a lab coat as she visits the new production facility for sterile glass vials at the Sanofi pharmaceuticals plant on May 28, 2015 in Frankfurt, Germany. Merkel is visiting the factory, which produces antibiotics and insulin, ahead of the upcoming G7 summit, where the global struggle against antibiotic-resistant bacteria is among topics to be discussed by G7 leaders. *** (FOTO: DUKAS/ACTIONPRESS)
DUKAS/ACTIONPRESS -
DUKAS_50550055_ACP
Merkel bei Sanofi
Bundeskanzlerin Angela Merkel bei der Einweihung einer neuen Fertigungslinie für Insuline beim Pharmaunternehmen Sanofi im Industriepark Höchst in Frankfurt am Main / 280515
***FRANKFURT AM MAIN, GERMANY - MAY 28: German Chancellor Angela Merkel (L) wears a lab coat as she visits the new production facility for sterile glass vials at the Sanofi pharmaceuticals plant on May 28, 2015 in Frankfurt, Germany. Merkel is visiting the factory, which produces antibiotics and insulin, ahead of the upcoming G7 summit, where the global struggle against antibiotic-resistant bacteria is among topics to be discussed by G7 leaders. *** (FOTO: DUKAS/ACTIONPRESS)
DUKAS/ACTIONPRESS -
DUKAS_50550053_ACP
Merkel bei Sanofi
Bundeskanzlerin Angela Merkel bei der Einweihung einer neuen Fertigungslinie für Insuline beim Pharmaunternehmen Sanofi im Industriepark Höchst in Frankfurt am Main / 280515
***FRANKFURT AM MAIN, GERMANY - MAY 28: German Chancellor Angela Merkel (3rdR) inspects an insulin pen as she visits the new production facility for sterile glass vials at the Sanofi pharmaceuticals plant on May 28, 2015 in Frankfurt, Germany. Sanofi Germany generalmanager Martin Siewert, CEO of Sanofi Olivier Brandicourt and the mayor of Frankfurt Peter Feldmann (L-R) stand by side. Merkel is visiting the factory, which produces antibiotics and insulin, ahead of the upcoming G7 summit, where the global struggle against antibiotic-resistant bacteria is among topics to be discussed by G7 leaders. *** (FOTO: DUKAS/ACTIONPRESS)
DUKAS/ACTIONPRESS -
DUKAS_50550050_ACP
Merkel bei Sanofi
Bundeskanzlerin Angela Merkel bei der Einweihung einer neuen Fertigungslinie für Insuline beim Pharmaunternehmen Sanofi im Industriepark Höchst in Frankfurt am Main / 280515
***FRANKFURT AM MAIN, GERMANY - MAY 28: (L-R) The mayor of Frankfurt Peter Feldmann, German Chancellor Angela Merkel, the Hessian minister of science and arts Boris Rhein and Sanofi CEO Olivier Brandicourt start the new production facility for sterile glass vials at the Sanofi pharmaceuticals plant on May 28, 2015 in Frankfurt, Germany. Merkel is visiting the factory, which produces antibiotics and insulin, ahead of the upcoming G7 summit, where the global struggle against antibiotic-resistant bacteria is among topics to be discussed by G7 leaders. *** (FOTO: DUKAS/ACTIONPRESS)
DUKAS/ACTIONPRESS -
DUKAS_50550048_ACP
Merkel bei Sanofi
Bundeskanzlerin Angela Merkel bei der Einweihung einer neuen Fertigungslinie für Insuline beim Pharmaunternehmen Sanofi im Industriepark Höchst in Frankfurt am Main / 280515
***FRANKFURT AM MAIN, GERMANY - MAY 28: German Chancellor Angela Merkel (C) wears a lab coat as she visits the new production facility for sterile glass vials at the Sanofi pharmaceuticals plant on May 28, 2015 in Frankfurt, Germany. Merkel is visiting the factory, which produces antibiotics and insulin, ahead of the upcoming G7 summit, where the global struggle against antibiotic-resistant bacteria is among topics to be discussed by G7 leaders. *** (FOTO: DUKAS/ACTIONPRESS)
DUKAS/ACTIONPRESS -
DUKAS_50550045_ACP
Merkel bei Sanofi
Bundeskanzlerin Angela Merkel bei der Einweihung einer neuen Fertigungslinie für Insuline beim Pharmaunternehmen Sanofi im Industriepark Höchst in Frankfurt am Main / 280515
***FRANKFURT AM MAIN, GERMANY - MAY 28: German Chancellor Angela Merkel (R) wears a lab coat as she visits the new production facility for sterile glass vials at the Sanofi pharmaceuticals plant on May 28, 2015 in Frankfurt, Germany. Merkel is visiting the factory, which produces antibiotics and insulin, ahead of the upcoming G7 summit, where the global struggle against antibiotic-resistant bacteria is among topics to be discussed by G7 leaders. *** (FOTO: DUKAS/ACTIONPRESS)
DUKAS/ACTIONPRESS -
DUKAS_50550044_ACP
Merkel bei Sanofi
Bundeskanzlerin Angela Merkel bei der Einweihung einer neuen Fertigungslinie für Insuline beim Pharmaunternehmen Sanofi im Industriepark Höchst in Frankfurt am Main / 280515
***FRANKFURT AM MAIN, GERMANY - MAY 28: German Chancellor Angela Merkel (R) wears a lab coat as she visits the new production facility for sterile glass vials at the Sanofi pharmaceuticals plant on May 28, 2015 in Frankfurt, Germany. Merkel is visiting the factory, which produces antibiotics and insulin, ahead of the upcoming G7 summit, where the global struggle against antibiotic-resistant bacteria is among topics to be discussed by G7 leaders. *** (FOTO: DUKAS/ACTIONPRESS)
DUKAS/ACTIONPRESS -
DUKAS_50550041_ACP
Merkel bei Sanofi
Bundeskanzlerin Angela Merkel bei der Einweihung einer neuen Fertigungslinie für Insuline beim Pharmaunternehmen Sanofi im Industriepark Höchst in Frankfurt am Main / 280515
***FRANKFURT AM MAIN, GERMANY - MAY 28: German Chancellor Angela Merkel (R) tests an insulin pen with (L-R) CEO of Sanofi Olivier Brandicourt and the mayor of Frankfurt Peter Feldmann, as she visits the new production facility for sterile glass vials at the Sanofi pharmaceuticals plant on May 28, 2015 in Frankfurt, Germany. Merkel is visiting the factory, which produces antibiotics and insulin, ahead of the upcoming G7 summit, where the global struggle against antibiotic-resistant bacteria is among topics to be discussed by G7 leaders. *** (FOTO: DUKAS/ACTIONPRESS)
DUKAS/ACTIONPRESS -
DUKAS_50550040_ACP
Merkel bei Sanofi
Bundeskanzlerin Angela Merkel bei der Einweihung einer neuen Fertigungslinie für Insuline beim Pharmaunternehmen Sanofi im Industriepark Höchst in Frankfurt am Main / 280515
***FRANKFURT AM MAIN, GERMANY - MAY 28: German Chancellor Angela Merkel (R) tests an insulin pen with (L-R) Sanofi Germany general manager Martin Siewert, CEO of Sanofi Olivier Brandicourt and the mayor of Frankfurt Peter Feldmann, as she visits the new production facility for sterile glass vials at the Sanofi pharmaceuticals plant on May 28, 2015 in Frankfurt, Germany. Merkel is visiting the factory, which produces antibiotics and insulin, ahead of the upcoming G7 summit, where the global struggle against antibiotic-resistant bacteria is among topics to be discussed by G7 leaders. *** (FOTO: DUKAS/ACTIONPRESS)
DUKAS/ACTIONPRESS -
DUKAS_50550037_ACP
Merkel bei Sanofi
Bundeskanzlerin Angela Merkel bei der Einweihung einer neuen Fertigungslinie für Insuline beim Pharmaunternehmen Sanofi im Industriepark Höchst in Frankfurt am Main / 280515
***FRANKFURT AM MAIN, GERMANY - MAY 28: German Chancellor Angela Merkel (C) wears a lab coat as she visits the new production facility for sterile glass vials at the Sanofi pharmaceuticals plant on May 28, 2015 in Frankfurt, Germany. Merkel is visiting the factory, which produces antibiotics and insulin, ahead of the upcoming G7 summit, where the global struggle against antibiotic-resistant bacteria is among topics to be discussed by G7 leaders. *** (FOTO: DUKAS/ACTIONPRESS)
DUKAS/ACTIONPRESS -
DUKAS_12519565_REX
Syringe and 500ml Bottle of Clear Fluid Carried on to a Plane 5 Days After Terror Attempt on a Delta Airlines Flight, Schipol Airport, Amsterdam, Netherlands - 30 Dec 2009
Mandatory Credit: Photo by Stuart Clarke / Rex Features ( 1076342f )
500ml of clear fluid in a glass bottle, An Insulin syringe and lighters which were taken through Amsterdam Schipol airport without checks on to a plane
British Newspaper Reveals Lack Of Security At Schipol Airport
BRITISH NEWSPAPER REVEALS LACK OF SECURITY AT SCHIPOL AIRPORT
A British investigative photojournalist has revealed shocking lapses of security on an international domestic flight - just five days after a Nigerian terrorist narrowly failed to properly detonate explosives on a flight on Christmas Day.
Stuart Clarke was sent by the Sunday Express newspaper to test out security measures at Amsterdam's Schipol airport the day before New Year's Eve - and he found them to be severely lacking.
As he boarded a flight from Amsterdam back to the United Kingdom, Mr Clarke was carrying on his person an insulin syringe which was not even found, let alone investigated to verify its authenticity.
Despite Umar Abdulmutallab's failed bombing attempt on December 25th leading to supposedly tightened security at international airports, Mr Clarke found that very little has changed: as well as the syringe, he managed to take with him an unexamined litre bottle of colourless liquid and two lighters, all of which could have contained materials which, when combined, can make a homemade explosive device.
He passed through the security control unchecked to board a flight along with scores of other passengers; even a cursory check by patting him down would have uncovered the syringe in his jacket pocket, which could have contained the same explosives used by 23-year-old Abdulmutallab on the flight from Schipol to Detroit at Christmas.
Despite UK security services upgrading the current terror alert level to 'substantial', no extra measures seem to be in place on this highly popular route from Schipol - one of aviation's ...
For more information visit http://www.rexfeatures.com/stacklink/EHZEXGXWB
DUKAS/REX -
DUKAS_12519564_REX
Syringe and 500ml Bottle of Clear Fluid Carried on to a Plane 5 Days After Terror Attempt on a Delta Airlines Flight, Schipol Airport, Amsterdam, Netherlands - 30 Dec 2009
Mandatory Credit: Photo by Stuart Clarke / Rex Features ( 1076342g )
500ml of clear fluid in a glass bottle, An Insulin syringe and lighters which were taken through Amsterdam Schipol airport without checks on to a plane
British Newspaper Reveals Lack Of Security At Schipol Airport
BRITISH NEWSPAPER REVEALS LACK OF SECURITY AT SCHIPOL AIRPORT
A British investigative photojournalist has revealed shocking lapses of security on an international domestic flight - just five days after a Nigerian terrorist narrowly failed to properly detonate explosives on a flight on Christmas Day.
Stuart Clarke was sent by the Sunday Express newspaper to test out security measures at Amsterdam's Schipol airport the day before New Year's Eve - and he found them to be severely lacking.
As he boarded a flight from Amsterdam back to the United Kingdom, Mr Clarke was carrying on his person an insulin syringe which was not even found, let alone investigated to verify its authenticity.
Despite Umar Abdulmutallab's failed bombing attempt on December 25th leading to supposedly tightened security at international airports, Mr Clarke found that very little has changed: as well as the syringe, he managed to take with him an unexamined litre bottle of colourless liquid and two lighters, all of which could have contained materials which, when combined, can make a homemade explosive device.
He passed through the security control unchecked to board a flight along with scores of other passengers; even a cursory check by patting him down would have uncovered the syringe in his jacket pocket, which could have contained the same explosives used by 23-year-old Abdulmutallab on the flight from Schipol to Detroit at Christmas.
Despite UK security services upgrading the current terror alert level to 'substantial', no extra measures seem to be in place on this highly popular route from Schipol - one of aviation's ...
For more information visit http://www.rexfeatures.com/stacklink/EHZEXGXWB
DUKAS/REX -
DUKAS_12519562_REX
Syringe and 500ml Bottle of Clear Fluid Carried on to a Plane 5 Days After Terror Attempt on a Delta Airlines Flight, Schipol Airport, Amsterdam, Netherlands - 30 Dec 2009
Mandatory Credit: Photo by Stuart Clarke / Rex Features ( 1076342b )
An Insulin syringe which was taken through Amsterdam Schipol airport without checks on to a plane
British Newspaper Reveals Lack Of Security At Schipol Airport
BRITISH NEWSPAPER REVEALS LACK OF SECURITY AT SCHIPOL AIRPORT
A British investigative photojournalist has revealed shocking lapses of security on an international domestic flight - just five days after a Nigerian terrorist narrowly failed to properly detonate explosives on a flight on Christmas Day.
Stuart Clarke was sent by the Sunday Express newspaper to test out security measures at Amsterdam's Schipol airport the day before New Year's Eve - and he found them to be severely lacking.
As he boarded a flight from Amsterdam back to the United Kingdom, Mr Clarke was carrying on his person an insulin syringe which was not even found, let alone investigated to verify its authenticity.
Despite Umar Abdulmutallab's failed bombing attempt on December 25th leading to supposedly tightened security at international airports, Mr Clarke found that very little has changed: as well as the syringe, he managed to take with him an unexamined litre bottle of colourless liquid and two lighters, all of which could have contained materials which, when combined, can make a homemade explosive device.
He passed through the security control unchecked to board a flight along with scores of other passengers; even a cursory check by patting him down would have uncovered the syringe in his jacket pocket, which could have contained the same explosives used by 23-year-old Abdulmutallab on the flight from Schipol to Detroit at Christmas.
Despite UK security services upgrading the current terror alert level to 'substantial', no extra measures seem to be in place on this highly popular route from Schipol - one of aviation's biggest transport hubs - to the United Kingdom.
The...
For more information visit http://www.rexfeatures.com/stacklink/EHZEXGXWB
DUKAS/REX -
